CLASS II Drug recall · Reported 15 Jun 2022 · FDA Enforcement Report

E-Z-Gas II, Effervescent Granules recalled by Mckesson Medical-Surgical

Mckesson Medical-Surgical Inc. Corporate Office is recalling E-Z-Gas II, Effervescent Granules, distributed nationwide in the US. The recall was initiated on 13 Apr 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesMcKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.
NDC10361-793
Quantity recalled16 boxes/50 pouches per box

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1085-2022
FDA event ID
89646
Brand
E-z-gas
Manufacturer
E-Z-EM, INC.
Classification
Class II
Status
Terminated
Recall initiated
13 Apr 2022
FDA classified
9 Jun 2022
Reported
15 Jun 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter

Timeline

13 Apr 2022Recall initiated by company
9 Jun 2022Classified by FDA+57 days
15 Jun 2022Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

cGMP deviations: Temperature abuse

Product as listed by the FDA

E-Z-Gas II, Effervescent Granules, Net Weight: 4 g, 50 packets per box, MFG: Bracco Diagnostics Inc., NDC 0270-9020-01 (discontinued), NDC 10361-793-01 (current)

Where it was distributed

USA nationwide.

Nationwide

Questions about this recall

Is E-Z-Gas II, Effervescent Granules recalled?

Yes. Mckesson Medical-Surgical Inc. Corporate Office recalled E-Z-Gas II, Effervescent Granules on 13 Apr 2022. The recall is Class II and its status is Terminated. Recall number D-1085-2022.

Why was it recalled?

cGMP deviations: Temperature abuse

Which lots are affected?

McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.

Where was it sold?

USA nationwide.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Mckesson Medical-Surgical Inc. Corporate Office

All 276

Other Antacid/antiflatulent recalls

All 2
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIIE-z- Gas II Effervescent Granules Antacid/Antiflatulent recalledE-z-gasBracco DiagnosticPotency & AssayNationwide